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Endothelium properties of a tissue-engineered
blood vessel for small-diameter vascular
reconstruction
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Purpose: A tissue-engineered blood vessel (TEBV) produced in vitro by the self-assembly method was developed in our
laboratory for the replacement of small-diameter blood vessels. The interior of this vessel is covered by an endothelium.
The aim of the present study was to evaluate whether the endothelial layer would make a favorable contribution at the
time of implantation of the TEBV by investigating in vitro the hemocompatible properties of the endothelial cells
covering its interior.
Methods: The secretion of the von Willebrand factor (vWF) and expression of thrombomodulin by the endothelium were
assessed, and the adhesive molecules E-selectin and intercellular adhesion molecule-1 (ICAM-1) were quantified as a
function of maturation time. To evaluate the functional response of the endothelium on injury, the cellular response to
physiological stimulatory factors (thrombin and lipopolysaccharide [LPS]) was analyzed.
Results: The endothelial cells formed a confluent monolayer displaying favorable hemocompatible properties (78% 10%
of cells expressing thrombomodulin with only 12  3 mU/106 cells of vWF secreted over a 2-hour period), which
acquired their full expression after a culture period of 4 days. Moreover, pro-adhesive properties toward inflammatory
cells were not observed. The cells were also able to respond to physiological-stimulating agents (thrombin and LPS) and
demonstrated a statistically significant overexpression of the corresponding molecules under the conditions tested.
Conclusions: These results indicate that the endothelium of the tissue-engineered blood vessel produced by the
self-assembly approach displays advantageous qualities with regard to the vessel’s future implantation as a small-diameter
vascular prosthesis. (J Vasc Surg 2004;39:613-20.)
The production of small-diameter prostheses for graft-
ing in patients who suffer from occlusions is still under
intensive investigation1-5 to improve their long-term pa-
tency under low blood flow conditions combined with the
pathologic context. Even though the strategies presented
in the literature to overcome this problem differ in their
approach (ie, artificial, biodegradable, biologic conduits),
the hemocompatibility of the prostheses is a critical point to
consider in small-diameter blood vessel (5 mm) replace-
ment.6,7 Among the strategies developed, the production
of a completely biologic tissue-engineered blood vessel
(TEBV) comprising the natural compartments of a native
vessel is an attractive alternative for closely approaching the
in vivo properties of a blood vessel.
In 1998, we reported a new vascular prosthesis pro-
duced by the “self-assembly approach” that was composed
exclusively of cells embedded in their own extracellular
matrix.8,9 This entirely biologic conduit presents the mac-
roscopic and microscopic characteristics of a natural vessel
and is strong enough to support physiological blood pres-
sure without any exogenous additional reinforcement.9
The TEBV is self-supporting and is composed of the three
histologic layers of a blood vessel (adventitia, media, and
intima). The monolayer of endothelial cells rests on a
decellularized biologic extracellular matrix, named the IM
(inner membrane), which is composed of a scaffold of
extracellular matrix components produced by human der-
mal fibroblasts in culture.9
To evaluate whether the endothelial cells could confer
the necessary hemocompatible properties to the model, the
functional (hemostatic and pro-adhesive) properties of this
endothelium were assessed. The secretion of the von Wil-
lebrand factor (vWF) and the expression of thrombomodu-
lin on the surface of human umbilical vein endothelial cells
(HUVECs) in contact with the IM were analyzed because
of their importance in the coagulation process in vivo and
because they have been the object of numerous studies as
potential markers of vascular damage.10 The analysis of the
adhesive proteins E-selectin and intercellular adhesion mol-
ecule-1 (ICAM-1), as indicators of the adhesiveness of the
immune cells, was also undertaken because the molecules
that adhere to leukocytes are up-regulated by endothelial
cells and correlate with the severity and/or stage of rejec-
tion in organ transplantations.11-13 Our results indicate
that the intima of our TEBV displays encouraging proper-
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ties with regard to thrombosis as well as inflammation, after
a minimal in vitro maturation period of 4 days following
endothelial cell seeding on the IM.
MATERIAL AND METHODS
Endothelial cell harvesting and culture. Human
umbilical vein endothelial cells were isolated according to
the original procedure described by Jaffe et al,14 except that
a thermolysin digestion (250 g/mL in HEPES [N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid] buffer
supplemented with 1 mM CaCl2; Sigma, St. Louis, Mo)
was performed for 30 minutes at 37°C.15 Endothelial cells
were cultured with M199, supplemented with 20% bovine
serum (Hyclone, Logan, Utah), 2 mM L-glutamine, 50
U/mL heparin, 25 g/mL endothelial cell growth supple-
ment (Sigma), 100 U/mL penicillin G, and 25 g/mL
gentamicin, and used at passage four or five in all
experiments.
Preparation of the IM. Inner membranes were pro-
duced either in 2-cm2 chambers or in 75-cm2 culture flasks,
depending on the experimental needs. The small chambers
were used for the quantification of the proteins secreted by
the endothelial cells in a fixed volume of 2 mL. The
augmented surface of the larger flasks was required to
obtain the greater number of cells necessary for fluores-
cence activated cell scanning (FACS) analysis. Human skin
fibroblasts were isolated and cultured on plastic as de-
scribed previously.15 For the IM production, fibroblasts
from passages three to nine were seeded at 104 cells/cm2 in
0.02% gelatin precoated culture flasks and cultured for 30
days, as previously described.9 The cells formed a progres-
sively thicker sheet composed of cells surrounded by an
abundant extracellular matrix (ECM). For decellularization
of the IM, the culture medium was removed, and the
tissues were rinsed three times in distilled water, dried at
room temperature, and stored at20°C until use. The IMs
were either kept in their original culture chambers for
subsequent experiments (for 2-cm2) or placed to cover the
bottom of new 100-mm Petri dishes.
Seeding and culture of endothelial cells on IM. Ex-
cept for the determination of the cell density over the time
of maturation, in which 105 cells/cm2 of support were
seeded, endothelial cells were systematically seeded at 5 
104/cm2. These two densities led to a direct confluence of
endothelial cells on the IM on the day of seeding. There-
fore, the day of seeding was named “day 0 after conflu-
ence,” and the subsequent days were considered as day 1
after confluence to day 8 after confluence. Cells were
cultured for 8 days, and the medium was changed every 48
hours.
Scanning electron microscopy analysis. Samples
were fixed in 2% glutaraldehyde, rinsed in 0.1 M cacodylate
buffer, and processed for scanning electron microscopy.
Immunofluorescent staining. Endothelial cells cul-
tured on the IM or on plastic were fixed by formalin (4% in
phosphate-buffered saline [PBS]) during 20 minutes at
room temperature before labeling with anti–von Wille-
brand Factor (vWF) (Sigma), anti-CD 31 (DAKO Diag-
nostics, Mississauga, Canada) or anti–vascular endothelial
cadherin (VE-cadherin; Chemicon, El Segundo, Calif) an-
tibodies followed by the relevant rhodamine-conjugated
secondary antibody. Nuclei were stained blue with Hoechst
33258.
Incorporation of neutral red for the determination
of cell density. Cells cultured on the IM or on plastic were
stained with neutral red (Sigma) as previously described.16
The absorbance at 540 nm was measured by a microtiter
plate spectrophotometer.
Cell preparation for flow cytometry analysis. When
specified, the cells were stimulated for 6 or 24 hours with 5
g/mL lipopolysaccharide (LPS; Sigma; Escherichia coli
026:B6) added to the culture medium. At the end of this
incubation period, all the cells were detached from the
supports (IM or plastic) by treatment with thermolysin
(250 g/mL in HEPES buffer1 mM CaCl2) at 37°C for
a maximum period of 30 minutes. The cells were regularly
observed for the degree of detachment, and the thermoly-
sin solution was collected as well as the subsequent washes
(calcium-free HEPES) when the detachment was com-
pleted. The cells were pelleted by centrifugation and sub-
sequently treated with 2 mL trypsin-EDTA (0.05%-0.01%)
for exactly 2 minutes at 37°C with constant gentle mixing.
For thrombomodulin analysis, freshly detached cells were
transferred to a PBS-BSA-glucose buffer (PBS pH 7.4, 20
mM glucose, 1% bovine serum albumin) and immediately
processed for flow cytometry. For ICAM-1 and E-selectin
analyses, cells were fixed in 70% ethanol and kept frozen
until further used.
Flow cytometry analysis. Fixed cells were labeled at
room temperature in PBS-1% BSA (pH 7.4). For the label-
ing of fresh cells, 20 mM D-glucose was added to the
PBS-1% BSA, and the processing was performed on ice.
The cells were immunostained for FACS analyses with
the following antibodies: polyclonal rabbit antithrombo-
modulin (diluted 1/3; Cedarlane Laboratories, Hornby,
Canada), mouse monoclonal anti–E-selectin and anti–
ICAM-1 (diluted 1/400 and 1/500, respectively; R&D
Systems, Abingdon, United Kingdom) and Alexa 488-
conjugated secondary antibody (Molecular Probes, Eu-
gene, Ore). The analysis was performed with a Becton
Dickinson cytometer (San Jose, Calif). Results are the mean
of 6 to 10 independent experiments.
Hemostatic parameters measurements. Twenty-
four hours before harvesting, the culture medium was
changed for a medium containing (stimulated secretion) or
lacking (basal secretion) 2 U/mL thrombin (Parke-Davis,
Scarborough, Canada). Culture media were collected, cen-
trifuged at 4°C to discard any cells present, and frozen at
80°C until assessed. The vWF was quantified by specific
enzyme-linked immunosorbent assay (ELISA; Diagnostica
Stago, Asnieres, France) according to the manufacturer’s
specifications. Results are the mean of four independent
experiments with two different cell lines, each experiment
contained three measurements per time point.
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Statistical analyses. Values are expressed as mean 
SEM. The statistical significance was tested by an unpaired
Student t test. P  .05 was considered significant.
RESULTS
Characterization of the endothelium lining the IM
support
The cell seeding concentration was chosen to minimize
the effect of cell density on the measurement of endothe-
lium properties by keeping it constant over the whole
period of experimentation. Cell adhesion experiments (re-
peated eight times) with an initial density of 105 cells/cm2
gave the following results. The adhesion of 70% of the cells
was observed after 24 hours (69,200  7400 cells/cm2).
The cell density decreased to approximately 50% of the
initial cell seeding density by day 3 and remained stable
until day 8, which corresponded to the day chosen for graft
implantation in our previous experiments with TEBV be-
cause the endothelial cells formed a confluent monolayer.9
At day 8, we obtained 50,400 5400 cells/cm2 on the IM
and 47,500  10,700 cells/cm2 on the plastic control.
Thus, all subsequent experiments were carried out by seed-
ing 5  104 cells/cm2, a cell density that remained effec-
tively constant after culture. In such experimental condi-
tions, the endothelial cells seeded either on plastic or IM
produced a confluent monolayer on the day of seeding.
Therefore, the only variable tested in our study was the
influence of the substrates (plastic or IM).
To evaluate whether endothelial cell markers were con-
served when HUVECs were cultured for four to five pas-
sages and seeded on the IM or on plastic (control), intra-
cytoplasmic vWF was immunolabeled 8 days after seeding.
Endothelial cells cultured either on the IM or on the plastic
presented the characteristic vWF labeling in cytoplasmic
granules (Fig 1). Preservation of the monolayer integrity
was assessed by labeling intercellular molecules localized at
cell-cell junctions,17 ie, CD31 (platelet endothelial cell
adhesion molecule-1 [PECAM-1]), and the specific adhe-
sion molecule VE-cadherin. Both these markers were
present at the intercellular junctions of the endothelial cells
cultured on the IM as well as on the plastic control, and the
labeling shows the confluence of the endothelium at 8 days
after seeding (Fig 1). The integrity of the endothelium as
well as the complete coverage of the IM by the endothelial
cells was confirmed by scanning electron microscopy (Fig
2).
Hemostatic parameters of the endothelium lining the
IM
To compare the hemostatic properties of endothelial
cells cultured on plastic and IM substrates, the secretion of
vWF was evaluated by specific ELISA, whereas the expres-
sion of thrombomodulin was measured by FACS analysis.
vWF secretion. Endothelial cells secreted a basal level
of vWF at all times during the maturation period. Except
for 2 days after seeding on the IM, a statistically significant
increase of the vWF secretion after stimulation with 2
U/mL thrombin was obtained in all experimental condi-
tions (Fig 3).
Fig 1. Immunofluorescent staining of HUVEC as a function of time. HUVEC were seeded at 5 104/cm2 on the IM
or the plastic control and cultured for 8 days. At this time, the cells were fixed on the supports and immunostained for
the presence of vWF, CD31, and VE-cadherin.
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Thrombomodulin expression. Because surface mol-
ecules such as thrombomodulin could be altered by trypsin
treatment if too long,18 preliminary experiments helped us
to design a protocol of specific detachment that allowed the
recovery of all endothelial cells without a deleterious effect
on surface molecules (data not shown). The optimal pro-
tocol was determined to be as follows: Cultures were incu-
bated with thermolysin for a maximal period of 30 minutes.
The cells were then detached as plaques (groups), which
then underwent a short digestion with trypsin/EDTA to
dissociate the cells (exactly 2 minutes of treatment with
0.05% trypsin/0.01% EDTA).
Approximately 80% of the endothelial cells expressed
the thrombomodulin antigen at their surface 2 days after
their attachment to both supports (Fig 4). The proportion
of cells expressing the molecule remained relatively stable
over time when seeded on the IM. In contrast, when cells
were cultured on plastic, this proportion decreased with
culture time (Fig 4). At 8 days after confluence, signifi-
cantly more cells on the IM expressed thrombomodulin
than were expressed on the plastic control (78%  10% vs
55% 4% respectively; P .001), indicating that a greater
number of endothelial cells cultured on the IM keep this
antithrombogenic protein at their surface.
Expression of adhesive molecules on endothelial cells
lining plastic or IM supports
To calculate the ratio of cells on the IM expressing
adhesive molecules to that of cells in plastic culture flasks,
endothelial cells were detached with the specific thermoly-
sin/trypsin procedure to perform cytofluorimetric analyses
of E-selectin and ICAM-1.
In basal conditions and as indicated in Fig 5, B, the
proportion of cells expressing E-selectin and ICAM-1 was
identical for cells cultured on plastic or the IM soon after
confluence (day 2 after confluence). The basal level of
adhesive proteins was not statistically different for longer
culture times despite a tendency of cells on the IM to
express fewer adhesive molecules than their counterparts
on the plastic control. The ratios remained the same during
the postconfluence experiments, although we observed an
up-regulation in the proportion of cells expressing the
markers. The latter being observed for both plastic and IM
supports, it is perhaps due to static culture conditions.
Fig 2. Scanning electron microscopy photography of the intimal layer after 8 days in culture. The IM alone (A) or
seeded with 5  104 HUVEC/cm2 (B) was kept in culture for 8 days before processing for scanning electron
microscopy.
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After stimulation with LPS, an increase in the number
of cells expressing E-selectin and ICAM-1 occurred regard-
less of the support and the time after confluence as indi-
cated by the values of the mean of fluorescence obtained by
the FACS curves (Fig 5, A). With respect to the expression
of E-selectin, the observed ratio was stable at 2 and 4 days
after confluence, indicating that cells on the plastic control
at these points in time respond to LPS stimulation to the
same extent as cells on the IM (Fig 5, C). At day 8, twice as
many cells in contact with the IM as cells in contact with the
plastic control responded to LPS stimulation (Fig 5, C).
The maximal values for E-selectin and ICAM-1 expression
after stimulation remained constant, indicating that these
values represent the maximal proportion of cells able to
respond to the stimulation: 51% 19% on plastic vs 62%
13% on IM and 87% 14% on plastic vs 86% 13% on IM
for E-selectin and ICAM-1, respectively, and at all times
during the experiments.
DISCUSSION
Hemocompatibility is a crucial factor to consider in the
development of vascular prostheses. Endothelial cell cover-
age is a promising avenue for conferring hemocompatible
properties.7,19 Endothelial cells must not only attach to the
prosthesis and cover it but they should also display func-
tional in vivo quiescent properties20 from the time of
implantation. The results of the present study indicate that
the endothelium of the TEBV produced in vitro by the
auto-assembly approach presents hemostatic and pro-adhe-
sive properties that suggest a favorable contribution in
regard to thrombosis and inflammation.
The quantification of prothrombotic and antithrom-
botic molecules produced by this endothelium enabled us
to assess the hemostatic balance, which is favorable to
anticoagulant properties in vivo. The cell density chosen for
the evaluation of the endothelial phenotype, 5  104
cells/cm2, results in a confluent cell monolayer 2 days after
seeding on the IM support. The 8-day in vitro maturation
period is comparable to that of other studies showing the
beneficial effect of in vitro maturation2,21,22 before implan-
tation.
The secretion of procoagulant vWF measured was sim-
ilar to that expected for cells in vivo.23 In resting condi-
tions, the secretion of vWF measured for endothelial cells
on plastic as well as on the IM was in the range of previously
published values measured in vitro for HUVECs lying on
artificial materials (between 2 and 130 mU/h per 106
cells).24-27 Endothelial cells responded to thrombin stimu-
lation by increasing their basal secretion, except at 2 days
after confluence on the IM, indicating that a 4-day matu-
ration on the IM is favorable to the establishment of a stable
cell phenotype and the associated functions. The twofold
increase in vWF secretion is in the range of values reported
by others (less than twofold25,26 to eightfold27,28).29 Thus,
the procoagulant vWF is secreted in a functional manner by
endothelial cells cultured on the IM. But a minimal period
Fig 3. Basal and stimulated secretions of vWF by HUVECs as a function of time. HUVECs were seeded at 5 
104/cm2 on the IM or the plastic control and cultured for 2, 4, or 8 days. At these times, the cells were incubated for
2 hours in the presence or absence of 2 U/mL thrombin. Supernatants were then collected, and the amount of vWF
secreted was measured by ELISA. Bars indicate standard deviations. (**P  .001) Statistically significant difference
between stimulated and nonstimulated cells on the correspondent support.
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of 4 days is suitable for the establishment of a totally
functional endothelium before the implantation of the
TEBV. The thrombomodulin expression was stable over
time for endothelial cells cultured on IM. It did not de-
crease as observed for cells cultured on plastic at day 8,
suggesting a better conservation of the anticoagulant path-
way of the endothelium when cultured on the biological
IM. Although they will have to be confirmed by in vivo
studies, such results are very encouraging, considering the
central role of thrombomodulin in thromboresistance.
Also, the suggested dramatic decrease in thrombomodulin
expression as early as 1 day after implantation might partic-
ipate in the failure of re-implanted vein grafts in bypass
surgery.30
The expression of adhesive molecules on the endothe-
lium resting on plastic or on the IM was similar over time,
indicating that no pro-adhesive phenotype was initiated by
cells in contact with the biological IM compared with
plastic. Nevertheless, an increase in the proportion of cells
expressing the molecules occurs with time (for E-selectin as
well as for ICAM-1) on both supports. This occurrence
could be attributed to the static conditions, and the intro-
duction of more physiological conditions (shear stress)
could help the endothelium maintain its functional charac-
teristics.
LPS was chosen as a stimulator for adhesive molecules
because it is known to up-regulate E-selectin and ICAM-
1,31 and LPS is often implicated in cases of infection
Fig 4. Expression of thrombomodulin by HUVECs as a function of time. HUVECs were seeded at 5  104/cm2 on
the IM or the plastic control and cultured for 2, 4, or 8 days. At these times, the cells were removed from their supports
by the thermolysin/trypsin treatment and immediately labeled and analyzed by FACS for the membrane expression of
thrombomodulin. A, Representative FACS curves with the mean values of fluorescence (MIF) (red line, unlabeled cells;
green line, immunolabeled cells). B, Mean percentage of cells expressing the thrombomodulin as a function of time.
Bars indicate standard deviations. Asterisks indicate a statistically significant difference (**P  .001).
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leading to the failure of implanted grafts.32-34 Cells in
contact with the IM as well as cells on the plastic control
both responded to LPS by overexpressing E-selectin and
ICAM-1, except for a reduced response of E-selectin on
day 8 in cells cultured on plastic. The modulation of the
expression of adhesive molecules according to the substrate
on which they are cultured is well known.35,36 The absence
of pro-adhesive molecules in resting conditions might sug-
gest that, in the TEBV, endothelial cells would not recruit
a massive number of leukocytes that could contribute to the
destabilization of the monolayer structure, thus leading to
a more prothrombotic environment after implantation.
Moreover, the preservation of the adhesive molecule re-
sponse to stimulation is an encouraging sign of the presence
of a fully functional endothelium in regard to inflammatory
processes.
As mentioned before, these results were obtained in the
absence of any mechanical loading, such as shear stress or
the pulsatile conditions that are present in vivo. Indeed, the
introduction of such mechanical stresses could modulate
the properties displayed by the endothelium37,38 and its
adhesiveness to the support.39 We have shown that at least
4 days of static conditions are necessary to obtain a stable
monolayer of functional cells on the biological IM. We are
presently studying the possibility of introducing a shear
stress after this critical period to improve our prosthesis.
In conclusion, this study indicates that the intima of the
TEBV displays encouraging properties in regard to throm-
bosis as well as inflammation, after an in vitro maturation
period of 4 days after endothelial cell seeding on IM. The
tightly joined endothelial cell monolayer does not produce
unacceptable quantities of procoagulant vWF. Thrombo-
modulin, the major anticoagulant molecule for thrombo-
resistance, is present at all times during the maturation
period. Taken together with previous results showing that
the endothelium of the TEBV does not allow platelet
adhesion,9 these results clearly indicate the presence of the
functional anticoagulant properties of endothelial cells.
The intima displays favorable properties for minimizing a
possible early inflammation process, as shown by the ab-
sence of pro-adhesive molecule expression, but maintains
its functional responses toward coagulation and inflamma-
tion. These properties involved in the healing process are
interesting for the TEBV with an expected wound healing
capacity related to its cell-based construction. Therefore, in
addition to the morphologic and functional characteristics
Fig 5. Expression of E-selectin and ICAM-1 adhesion molecules as a function of time. HUVECs were seeded at 5 
104/cm2 on the IM or the plastic control and cultured for 2, 4, and 8 days. The cells were stimulated or not with 10
g/mL LPS for 6 and 24 hours before the chosen time of harvesting for E-selectin and ICAM-1 detection, respectively.
At the time of harvesting, the cells were detached from their supports by the thermolysin/trypsin treatment and then
fixed. Labeling and FACS analyses were then carried out for the detection of the two adhesive molecules. The results
are shown as the ratio of molecules expressed by HUVECs cultured on the IM to molecules expressed by HUVECs
cultured on the plastic control. A, Representative FACS curves with their mean fluorescence (MIF) (black line,
unlabeled cells; red line, cells in resting conditions; green line, cells after LPS stimulation); B, ratios for nonstimulated
cells; C, ratios for LPS-stimulated cells. Bars indicate standard deviations. Asterisks indicate a statistically significant
difference (*P  .05).
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displayed by the TEBV, the functional endothelium should
ensure the patency of this small-diameter vascular prosthe-
sis after implantation. Work is in progress to undertake in
vivo studies.
We thank Louise Vu, from the Haematology Depart-
ment of the Saint-Sacrement Hospital, for her assistance in
the evaluation of hemostasis parameters and Cindy Hay-
ward for critical review of the paper.
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